Although these previous studies have characterized the identity of immune infiltrates in IDH wild-type and mutant gliomas, the causal relationship between IDH genetic status and tumor-infiltrating immune cells remains a subject for future studies. This evidence concerns the gene IDH1 and central nervous system cancer.